Related Funds
Funds with similar focus
Fund Name | Location |
Clarkston-Potomac | Durham, North Carolina, United States |
CP Holdings | Anhui, China, Macao |
Elite Network | Japan, Tokyo |
First Partners Holding 5 | Norway, Oslo |
Genesys Venture | Canada, Manitoba, Winnipeg |
Hefei Gaoxin Development & Investment Group Company | Anhui, China, Hefei |
HMC Ventures | China, Hangzhou, Zhejiang |
Kangmei Pharmaceutical | China, Guangdong Province, Huizhou |
Lumos Capital Group | California, San Francisco, United States |
National Treasury Management Agency (NTMA) | County Dublin, Dublin, Ireland |
NIIF Ltd. | India, Maharashtra, Mumbai |
Porte Monnaie | - |
Savannah Fund | Kenya, Nairobi, Nairobi Area |
Sejong Venture Partners | Fort Lee, New Jersey, United States |
Shanghai Ruiyan Touzi Guanli Co., Ltd. | China, Shanghai |
Squared Circles | New York, New York, United States |
Stage Group | - |
Sybat | France, Gennevilliers, Ile-de-France |
Zhihe Capital | Beijing, Beijing, China |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Booster Therapeutics | 10 Oct 2024 | Berlin, Berlin, Germany | |||
Aeovian Pharmaceuticals | $50M | 28 Mar 2024 | San Francisco, California, United States | ||
Cleara Biotech | $2M | 28 Sep 2022 | Utrecht, Utrecht, Netherlands | ||
Auron Therapeutics | $48M | 20 Jul 2022 | Massachusetts, United States | ||
HAYA Therapeutics | $5M | 09 Feb 2022 | Lausanne, Vaud, Switzerland | ||
Bloom Science | $12M | 09 Dec 2021 | San Diego, California, United States | ||
Ochre Bio | $9M | 16 Jun 2021 | Oxford, England, United Kingdom | ||
HAYA Therapeutics | $19M | 20 May 2021 | Lausanne, Vaud, Switzerland | ||
HAYA Therapeutics SA | $18M | 05 May 2021 | - |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Booster Therapeutics | 10 Oct 2024 | Berlin, Berlin, Germany | |||
Aeovian Pharmaceuticals | $50M | 28 Mar 2024 | San Francisco, California, United States | ||
Cleara Biotech | $2M | 28 Sep 2022 | Utrecht, Utrecht, Netherlands | ||
Auron Therapeutics | $48M | 20 Jul 2022 | Massachusetts, United States | ||
HAYA Therapeutics | $5M | 09 Feb 2022 | Lausanne, Vaud, Switzerland | ||
Bloom Science | $12M | 09 Dec 2021 | San Diego, California, United States | ||
Ochre Bio | $9M | 16 Jun 2021 | Oxford, England, United Kingdom | ||
HAYA Therapeutics | $19M | 20 May 2021 | Lausanne, Vaud, Switzerland | ||
HAYA Therapeutics SA | $18M | 05 May 2021 | - |